作者: Bernat Isern Amengual , Carolina Salcedo Roca , Miguel David Ferrer Reynes , Pieter H. Joubert , Joan Perello Bestard
DOI:
关键词:
摘要: Use of a derivative containing C—O—P bonds in controlled release form to treat patients with kidney failure. Moreover, it comprises the use said derivatives together other active substances, which particularly may be selected from list comprising calcimirnetic, vitamin, phosphate binder, thiosulfate, bisphosphonate, pyrophosphate, citrate, diuretic, antihypertensive and anticholesteraemic agent.